-
My Account
In App
My Account
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 4942 | 137.90 | 138.00 | 50 |
| 40 | 137.40 | 138.15 | 400 |
| 480 | 137.00 | 138.70 | 500 |
| 555 | 136.95 | 138.85 | 25 |
| 1 | 136.60 | 139.00 | 75 |
| 0 | Total | Total | 0 |
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 4942 | 137.90 | 138.00 | 50 |
| 40 | 137.40 | 138.15 | 400 |
| 480 | 137.00 | 138.70 | 500 |
| 555 | 136.95 | 138.85 | 25 |
| 1 | 136.60 | 139.00 | 75 |
| 0 | Total | Total | 0 |
| Open | 137.33 |
| Previous Close | 135.91 |
| Volume | 1,510,650.00 |
| Value (Lacs) | 2,083.04 |
| VWAP | 139.17 |
| Beta | |
| Mkt Cap (Rs. Cr.) | 4,475 |
| High | 142.00 |
| Low | 136.51 |
| UC Limit | 163.09 |
| LC Limit | 108.73 |
| 52 Week High | 204.40 |
| 52 Week Low | 109.30 |
| Face Value | 1.00 |
| All Time High | 593.93 |
| All Time Low | 35.17 |
| 20D Avg Volume | 1,544,686 |
| 20D Avg Delivery(%) | 23.97 |
| Book Value Per Share | -10.62 |
| Dividend Yield | 0.00 |
| TTM EPS See historical trend | -8.23 |
| TTM PE See historical trend | -- (Low PE) |
| P/B See historical trend | 0.00 |
| Sector PE | 40.86 |
*Delayed by 20 seconds.
Stock Score
Get detailed analysis with Moneycontrol Stock Insights.
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| Days | |
|---|---|
| 5 | - - |
| 10 | - - |
| 20 | - - |
| 50 | - - |
| 100 | - - |
| 200 | - - |
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| Days |
|---|
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| Days |
|---|
| 1 Week | --% | |
| 1 Month | --% | |
| 3 Months | --% | |
| YTD | --% | |
| 1 Year | --% | |
| 3 Years | --% |
10 out of 17 years Sun Pharma Advanced Research Company has given negative returns in January.
| Month | Max. Positive Change(%) | Avg. Positive Change(%) | Max. Negative Change(%) | Avg. Negative Change(%) | Average Change(%) |
|---|---|---|---|---|---|
| January | 75.78% (2015) | 25.72% | -20.27% (2025) | -10.12% | 3.32% |
Sun Pharma Adv Consolidated September 2025 Net Sales at Rs 7.86 crore, down 38.88% Y-o-Y Nov 17 2025 02:53 PM
Sun Pharma Adv Standalone September 2025 Net Sales at Rs 7.86 crore, down 38.88% Y-o-Y Nov 12 2025 03:08 PM
Sun Pharma Adv Consolidated June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y Aug 12 2025 11:23 AM
Sun Pharma Adv Standalone June 2025 Net Sales at Rs 9.64 crore, down 42.65% Y-o-Y Aug 05 2025 12:06 PM
Important milestones with tentative timelines for SPARC in 2026 include PRV voucher approval Feb 1st week, PDP716 Q1 acceptance to late 2026 approvals, SDN037 NDA filing Mid2026, SCO088 Phase 2 completion aug 2026. SCO088 oncology asset and PDP716 and SDN037 are opthalmology assets. Each of these milestones could result in out licensing deals , upfront and milestones based. View more
Posted by : serendip
Repost this message
Important milestones with tentative timelines for SPARC in 2026 include PRV voucher approval Feb 1st week, PDP716 Q1 acceptance to late 2026 approvals, SDN037 NDA filing Mid2026, SCO088 Phase 2 completion aug 2026. SCO088 oncology asset and PDP716 and SDN037 are opthalmology assets. Each of these milestones could result in out licensing deals , upfront and milestones based.
god know when good news will come and this stock will rally. View more
Posted by : prakin
Posted by : The Fixed Income
Repost this message
strengthen your investment portfolio with 12.44% returns vedika credit capital limited 2027 ✔️ coupon: 11.00% ✔️ rating: infomerics a- stable ✔️ tenor: 1y 4m (maturity date: 27/may/2027) senior secured | high-return | nbfc bond | listed step into stable, high-yield income with this secured nbfc bond. explore on the fixed income: https://www.thefixedincome.com/product/dvjtc1prpt0=/1100-vedika-credit-capital-limited-2027?utm_source=moneycontrol&utm_medium=forum&utm_campaign=product_list
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
| Qty 2898504 | Price 153.27 | % Traded 0.90 |
| Qty 2898504 | Price 153.34 | % Traded 0.90 |
| Qty 2131080 | Price 154.58 | % Traded 0.67 |
| Qty 1940152 | Price 153.84 | % Traded 0.60 |
| Qty 1940152 | Price 153.76 | % Traded 0.60 |
| Qty 1912360 | Price 154.79 | % Traded 0.60 |
| Qty 1376746 | Price 152.73 | % Traded 0.43 |
| Qty 1151539 | Price 152.44 | % Traded 0.36 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
| Date | Agenda |
|---|
| Ex-Date | Type | Dividend (Rs) |
|---|
| Announcement Date | Ex-Bonus | Ratio |
|---|
| Ex-Split | Old FV | New FV |
|---|
| Ex-Right | Ratio | Premium |
|---|
| Date | Agenda |
|---|
Sharpest Opinions & Actionable Insights 
Exclusive Webinars 
Research & Expert Technical Analysis 
